131 related articles for article (PubMed ID: 8103015)
1. In vitro detection of somatostatin receptors in human tumors.
Reubi JC; Krenning E; Lamberts SW; Kvols L
Digestion; 1993; 54 Suppl 1():76-83. PubMed ID: 8103015
[TBL] [Abstract][Full Text] [Related]
2. Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications.
Reubi JC; Laissue J; Krenning E; Lamberts SW
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):27-35. PubMed ID: 1356016
[TBL] [Abstract][Full Text] [Related]
3. In vitro detection of somatostatin receptors in human tumors.
Reubi JC; Krenning E; Lamberts SW; Kvols L
Metabolism; 1992 Sep; 41(9 Suppl 2):104-10. PubMed ID: 1355582
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptors in malignant tissues.
Reubi JC; Krenning E; Lamberts SW; Kvols L
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):1073-7. PubMed ID: 1981010
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo detection of somatostatin receptors in human malignant tissues.
Reubi JC; Kvols L; Krenning E; Lamberts SW
Acta Oncol; 1991; 30(4):463-8. PubMed ID: 1649613
[TBL] [Abstract][Full Text] [Related]
6. In vitro identification of vasoactive intestinal peptide receptors in human tumors: implications for tumor imaging.
Reubi JC
J Nucl Med; 1995 Oct; 36(10):1846-53. PubMed ID: 7562054
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells.
Hofland LJ; van Koetsveld PM; Wouters N; Waaijers M; Reubi JC; Lamberts SW
Endocrinology; 1992 Aug; 131(2):571-7. PubMed ID: 1322274
[TBL] [Abstract][Full Text] [Related]
8. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.
Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW
J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843
[TBL] [Abstract][Full Text] [Related]
9. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
Reubi JC; Kvols LK; Waser B; Nagorney DM; Heitz PU; Charboneau JW; Reading CC; Moertel C
Cancer Res; 1990 Sep; 50(18):5969-77. PubMed ID: 2168286
[TBL] [Abstract][Full Text] [Related]
10. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization.
Reubi JC; Schaer JC; Waser B; Mengod G
Cancer Res; 1994 Jul; 54(13):3455-9. PubMed ID: 8012966
[TBL] [Abstract][Full Text] [Related]
11. Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors.
Reubi JC; Horisberger U; Lang W; Koper JW; Braakman R; Lamberts SW
Am J Pathol; 1989 Feb; 134(2):337-44. PubMed ID: 2537015
[TBL] [Abstract][Full Text] [Related]
12. Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors.
Hofland LJ; De Herder WW; Visser-Wisselaar HA; Van Uffelen C; Waaijers M; Zuyderwijk J; Uitterlinden P; Kros MJ; Van Koetsveld PM; Lamberts SW
J Clin Endocrinol Metab; 1997 Sep; 82(9):3011-8. PubMed ID: 9284735
[TBL] [Abstract][Full Text] [Related]
13. Distribution of somatostatin receptors in normal and tumor tissue.
Reubi JC; Kvols L; Krenning E; Lamberts SW
Metabolism; 1990 Sep; 39(9 Suppl 2):78-81. PubMed ID: 2169575
[TBL] [Abstract][Full Text] [Related]
14. Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells.
Hofland LJ; van Koetsveld PM; Waaijers M; Zuyderwijk J; Lamberts SW
Endocrinology; 1994 Jan; 134(1):301-6. PubMed ID: 7903931
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin receptors in the thymus.
Ferone D; van Hagen PM; Colao A; Annunziato L; Lamberts SW; Hofland LJ
Ann Med; 1999 Oct; 31 Suppl 2():28-33. PubMed ID: 10574152
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells.
Ferone D; van Hagen PM; van Koetsveld PM; Zuijderwijk J; Mooy DM; Lichtenauer-Kaligis EG; Colao A; Bogers AJ; Lombardi G; Lamberts SW; Hofland LJ
Endocrinology; 1999 Jan; 140(1):373-80. PubMed ID: 9886848
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptors in human endocrine tumors.
Reubi JC; Maurer R; von Werder K; Torhorst J; Klijn JG; Lamberts SW
Cancer Res; 1987 Jan; 47(2):551-8. PubMed ID: 3024822
[TBL] [Abstract][Full Text] [Related]
18. Lack of evidence for autocrine feedback regulation by somatostatin in somatostatin receptor-containing meningiomas.
Reubi JC; Mengod G; Palacios JM; Horisberger U; Hackeng WH; Lamberts SW
Cell Growth Differ; 1990 Jun; 1(6):299-303. PubMed ID: 1980601
[TBL] [Abstract][Full Text] [Related]
19. Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues.
Reubi JC; Laissue J; Waser B; Horisberger U; Schaer JC
Ann N Y Acad Sci; 1994 Sep; 733():122-37. PubMed ID: 7978860
[TBL] [Abstract][Full Text] [Related]
20. Expression of somatostatin receptors in peritumoral veins of human tumors.
Denzler B; Reubi JC
Cancer; 1999 Jan; 85(1):188-98. PubMed ID: 9921992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]